Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 2, 2002

View Archived Issues

Antitumor activity of R-116010 is due to inhibition of all-trans-retinoic acid metabolism

Bivalirudin + abciximab for percutaneous coronary revascularization

Androgen suppression improves outcomes in the radiotherapy of locally advanced prostate cancer

Discovery Labs and Aerogen collaborate on aerosol-delivered surfactants

Genzyme Biosurgery and Myosix to advance autologous cell therapy for heart disease

BioTransplant revises development strategy for Allomune system

Phase III results of CDP-571 in Crohn's disease

TLK-19781 to enter clinic at Telik

Phase II/III Esterom trial completes enrollment

Inhibitors of protein kinase C and/or glycogen synthase kinase-3 in Ortho-McNeil patent

aaiPharma and Tanabe Seiyaku form joint venture

Cubist awarded SBIR grant for anthrax target research

Triangle reacquires product rights from Abbott

New carbapenem antibiotics emerge from Sumitomo R&D

Ortho-McNeil presents novel GnRH antagonists for infertility, prostate disorders, etc.

Selective adenosine A1 agonists for cardiovascular ischemic disorders claimed by GSK

Novel delta-opioid agonists/antagonists identified at Ortho-McNeil

P&G scientists describe novel benzimidazole with antitumor/antiviral activity

Iodinated alkenes with potential as X-ray contrast agents in Nycomed Imaging patent

Novel antithrombin agents prepared and tested at Servier

Prous Science webcasts the Mild Cognitive Impairment (MCI): State-of-the-Art Seminar

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...